Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab [Corrigendum]
Nudleman E, Wolfe JD, Woodward MA, Yonekawa Y, Williams GA, Hassan TS. Clinical Ophthalmology. 2016;10: 1053–1057.A units error was published on page 1055, column 2, as “3.1%”; the correct units are “μm” (3.1 μm).Read the original artic...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b04edf6e052e42608bde9d4d6babb983 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:b04edf6e052e42608bde9d4d6babb983 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:b04edf6e052e42608bde9d4d6babb9832021-12-02T05:13:45ZWorsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab [Corrigendum]1177-5483https://doaj.org/article/b04edf6e052e42608bde9d4d6babb9832017-02-01T00:00:00Zhttps://www.dovepress.com/corrigendum-worsening-anatomic-outcomes-following-aflibercept-for-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Nudleman E, Wolfe JD, Woodward MA, Yonekawa Y, Williams GA, Hassan TS. Clinical Ophthalmology. 2016;10: 1053–1057.A units error was published on page 1055, column 2, as “3.1%”; the correct units are “μm” (3.1 μm).Read the original article.Nudleman EWolfe JDWoodward MAYonekawa YWilliams GAHassan TSDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 11, Pp 355-356 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Ophthalmology RE1-994 |
spellingShingle |
Ophthalmology RE1-994 Nudleman E Wolfe JD Woodward MA Yonekawa Y Williams GA Hassan TS Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab [Corrigendum] |
description |
Nudleman E, Wolfe JD, Woodward MA, Yonekawa Y, Williams GA, Hassan TS. Clinical Ophthalmology. 2016;10: 1053–1057.A units error was published on page 1055, column 2, as “3.1%”; the correct units are “μm” (3.1 μm).Read the original article. |
format |
article |
author |
Nudleman E Wolfe JD Woodward MA Yonekawa Y Williams GA Hassan TS |
author_facet |
Nudleman E Wolfe JD Woodward MA Yonekawa Y Williams GA Hassan TS |
author_sort |
Nudleman E |
title |
Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab [Corrigendum] |
title_short |
Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab [Corrigendum] |
title_full |
Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab [Corrigendum] |
title_fullStr |
Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab [Corrigendum] |
title_full_unstemmed |
Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab [Corrigendum] |
title_sort |
worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab [corrigendum] |
publisher |
Dove Medical Press |
publishDate |
2017 |
url |
https://doaj.org/article/b04edf6e052e42608bde9d4d6babb983 |
work_keys_str_mv |
AT nudlemane worseninganatomicoutcomesfollowingafliberceptforneovascularagerelatedmaculardegenerationineyespreviouslywellcontrolledwithranibizumabcorrigendum AT wolfejd worseninganatomicoutcomesfollowingafliberceptforneovascularagerelatedmaculardegenerationineyespreviouslywellcontrolledwithranibizumabcorrigendum AT woodwardma worseninganatomicoutcomesfollowingafliberceptforneovascularagerelatedmaculardegenerationineyespreviouslywellcontrolledwithranibizumabcorrigendum AT yonekaway worseninganatomicoutcomesfollowingafliberceptforneovascularagerelatedmaculardegenerationineyespreviouslywellcontrolledwithranibizumabcorrigendum AT williamsga worseninganatomicoutcomesfollowingafliberceptforneovascularagerelatedmaculardegenerationineyespreviouslywellcontrolledwithranibizumabcorrigendum AT hassants worseninganatomicoutcomesfollowingafliberceptforneovascularagerelatedmaculardegenerationineyespreviouslywellcontrolledwithranibizumabcorrigendum |
_version_ |
1718400493398523904 |